Søren Melsing is the CEO of EXOCURE, a company harnessing the therapeutic and delivery potential of exosomes across oncology, inflammation, and beyond.

In this episode of Careers in Discovery, Søren shares his journey from chemical engineer to Biotech CEO, including leadership roles in R&D, commercial strategy, and company-building across Europe. He talks about learning by doing, transitioning from large pharma to start-up environments, and what it really takes to turn a scientific platform into a viable business.

We also explore the promise of exosomes as a new therapeutic modality, the realities of raising investment in a tough market, and why surrounding yourself with the right people - and staying curious - makes all the difference.